Table of Contents Europe Bioengineered Protein Drugs Market Report 2012-2023 1 Bioengineered Protein Drugs Overview 1.1 Product Overview and Scope of Bioengineered Protein Drugs 1.2 Classification of Bioengineered Protein Drugs by Product Category 1.2.1 Europe Bioengineered Protein Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Europe Bioengineered Protein Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 Therapeutic Proteins 1.2.4 Monoclonal Antibodies 1.2.5 Vaccines 1.3 Europe Bioengineered Protein Drugs Market by Application/End Users 1.3.1 Europe Bioengineered Protein Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Diabetes and Hormonal Disorders 1.3.3 Genetic and Fertility Disorders 1.3.4 Cancers 1.3.5 Organ Transplants 1.3.6 Others 1.4 Europe Bioengineered Protein Drugs Market by Region 1.4.1 Europe Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Germany Status and Prospect (2012-2023) 1.4.3 UK Status and Prospect (2012-2023) 1.4.4 France Status and Prospect (2012-2023) 1.4.5 Russia Status and Prospect (2012-2023) 1.4.6 Benelux Status and Prospect (2012-2023) 1.4.7 Italy Status and Prospect (2012-2023) 1.4.8 Spain Status and Prospect (2012-2023) 1.5 Europe Sales and Revenue ofSales and Revenue of Bioengineered Protein Drugs (2012-2023) 1.5.1 Europe Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Europe Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Bioengineered Protein Drugs 2.2 Raw Material Analysis of Bioengineered Protein Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Bioengineered Protein Drugs 2.4 Other Costs Analysis of Bioengineered Protein Drugs 2.5 Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs 2.6 Manufacturing Process Analysis of Bioengineered Protein Drugs 2.7 Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 Europe Bioengineered Protein Drugs Players/Suppliers Profiles and Sales Data 3.1 Abbott Laboratories 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Abbott Laboratories Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Abbott Laboratories Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.2 F. Hoffmann-La Roche Ltd 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 F. Hoffmann-La Roche Ltd Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.3 Amgen, Inc. 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Amgen, Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Amgen, Inc. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Amgen, Inc. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.4 Bayer AG 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Bayer AG Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Bayer AG Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Bayer AG Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.5 Merck & Co., Inc. 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Merck & Co., Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Merck & Co., Inc. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Merck & Co., Inc. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.6 Dr. Reddy's Laboratories Ltd. 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Dr. Reddy's Laboratories Ltd. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.7 Biocon Ltd. 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Biocon Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Biocon Ltd. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Biocon Ltd. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.8 Eli Lilly and Company 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Eli Lilly and Company Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Eli Lilly and Company Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Eli Lilly and Company Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.9 Sanofi 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Sanofi Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Sanofi Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.10 GlaxoSmithKline plc 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 GlaxoSmithKline plc Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 GlaxoSmithKline plc Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.11 Johnson & Johnson 3.12 JanssenNovartis AG 3.13 Panacea Biotec 3.14 ProBioGen AG 4 Europe Bioengineered Protein Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 Europe Bioengineered Protein Drugs Market Competition by Players/Manufacturers 4.1.1 Europe Bioengineered Protein Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Europe Bioengineered Protein Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Europe Bioengineered Protein Drugs Sales and Revenue by Type 4.2.1 Europe Bioengineered Protein Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Europe Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Europe Bioengineered Protein Drugs Sales and Revenue by Application 4.3.1 Europe Bioengineered Protein Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Europe Bioengineered Protein Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Europe Bioengineered Protein Drugs Sales (K Units) by Application 5 Germany Bioengineered Protein Drugs (Sales, Revenue and Price) 5.1 Germany Bioengineered Protein Drugs Sales and Value (2012-2017) 5.1.1 Germany Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Germany Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 5.1.3 Germany Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 Germany Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 5.3 Germany Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 6 UK Bioengineered Protein Drugs (Sales, Revenue and Price) 6.1 UK Bioengineered Protein Drugs Sales and Value (2012-2017) 6.1.1 UK Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 UK Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 6.1.3 UK Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 UK Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 6.3 UK Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 7 France Bioengineered Protein Drugs (Sales, Revenue and Price) 7.1 France Bioengineered Protein Drugs Sales and Value (2012-2017) 7.1.1 France Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 France Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 7.1.3 France Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 France Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 7.3 France Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 8 Russia Bioengineered Protein Drugs (Sales, Revenue and Price) 8.1 Russia Bioengineered Protein Drugs Sales and Value (2012-2017) 8.1.1 Russia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Russia Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Russia Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 Russia Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 8.3 Russia Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 9 Benelux Bioengineered Protein Drugs (Sales, Revenue and Price) 9.1 Benelux Bioengineered Protein Drugs Sales and Value (2012-2017) 9.1.1 Benelux Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 9.1.2 Benelux Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 9.1.3 Benelux Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 9.2 Benelux Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 9.3 Benelux Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 10 Italy Bioengineered Protein Drugs (Sales, Revenue and Price) 10.1 Italy Bioengineered Protein Drugs Sales and Value (2012-2017) 10.1.1 Italy Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Italy Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 10.1.3 Italy Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 10.2 Italy Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 10.3 Italy Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 11 Spain Bioengineered Protein Drugs (Sales, Revenue and Price) 11.1 Spain Bioengineered Protein Drugs Sales and Value (2012-2017) 11.1.1 Spain Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Spain Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 11.1.3 Spain Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 11.2 Spain Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 11.3 Spain Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Europe Bioengineered Protein Drugs Market Forecast (2018-2023) 13.1 Europe Bioengineered Protein Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Europe Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Europe Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Europe Bioengineered Protein Drugs Price and Trend Forecast (2018-2023) 13.2 Europe Bioengineered Protein Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Europe Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Europe Bioengineered Protein Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 Germany Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 UK Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 France Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Russia Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 France Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Italy Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Spain Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Europe Bioengineered Protein Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Europe Bioengineered Protein Drugs Sales Forecast by Type (2018-2023) 13.3.2 Europe Bioengineered Protein Drugs Revenue Forecast by Type (2018-2023) 13.3.3 Europe Bioengineered Protein Drugs Price Forecast by Type (2018-2023) 13.4 Europe Bioengineered Protein Drugs Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Europe Market Size (Million USD) Comparison 2012-2023 Table Europe Market Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table Europe Bioengineered Protein Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Europe Bioengineered Protein Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Bioengineered Protein Drugs Table Europe Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Europe Bioengineered Protein Drugs Sales (K Units) Market Share by Types in 2017 Figure Therapeutic Proteins Picture Figure Monoclonal Antibodies Picture Figure Vaccines Picture Table Europe Bioengineered Protein Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure Europe Sales Market Share of Bioengineered Protein Drugs by Applications in 2017 Figure Diabetes and Hormonal Disorders Picture Figure Genetic and Fertility Disorders Picture Figure Cancers Picture Table Europe Market Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure Germany Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure UK Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure France Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Russia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Benelux Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Italy Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Spain Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2023) Figure Europe Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Bioengineered Protein Drugs Table Industry News List of Bioengineered Protein Drugs Figure Industry Chain Structure of Bioengineered Protein Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs in 2017 Figure Manufacturing Process Analysis of Bioengineered Protein Drugs Table Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers Europe Table Major Buyers of Bioengineered Protein Drugs Table Abbott Laboratories Basic Information List Table Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Sales Europe Market Share (%) (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Revenue Europe Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Abbott Laboratories Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Abbott Laboratories Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Abbott Laboratories Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table F. Hoffmann-La Roche Ltd Basic Information List Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales Europe Market Share (%) (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Revenue Europe Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Amgen, Inc. Basic Information List Table Amgen, Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Sales Europe Market Share (%) (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Revenue Europe Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Amgen, Inc. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Amgen, Inc. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Amgen, Inc. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Bayer AG Basic Information List Table Bayer AG Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Sales Europe Market Share (%) (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Revenue Europe Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Bayer AG Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Bayer AG Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Bayer AG Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Merck & Co., Inc. Basic Information List Table Merck & Co., Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales Europe Market Share (%) (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Revenue Europe Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Dr. Reddy's Laboratories Ltd. Basic Information List Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales Europe Market Share (%) (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Revenue Europe Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Biocon Ltd. Basic Information List Table Biocon Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Sales Europe Market Share (%) (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Revenue Europe Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Biocon Ltd. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Biocon Ltd. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Biocon Ltd. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Eli Lilly and Company Basic Information List Table Eli Lilly and Company Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Sales Europe Market Share (%) (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Revenue Europe Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Eli Lilly and Company Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Eli Lilly and Company Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Eli Lilly and Company Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Sanofi Basic Information List Table Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Sanofi Bioengineered Protein Drugs Sales Europe Market Share (%) (2012-2017) Figure Sanofi Bioengineered Protein Drugs Revenue Europe Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Sanofi Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Sanofi Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Company GlaxoSmithKline plc Basic Information List Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company GlaxoSmithKline plc Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Company GlaxoSmithKline plc Bioengineered Protein Drugs Sales Europe Market Share (%) (2012-2017) Figure Company GlaxoSmithKline plc Bioengineered Protein Drugs Revenue Europe Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Europe Bioengineered Protein Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table Europe Bioengineered Protein Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Europe Bioengineered Protein Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 Europe Bioengineered Protein Drugs Sales Share by Players/Manufacturers Table Europe Bioengineered Protein Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Europe Bioengineered Protein Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Europe Bioengineered Protein Drugs Revenue Market Share (%) Players Figure 2017 Europe Bioengineered Protein Drugs Revenue Market Share (%) Players Table Europe Bioengineered Protein Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table Europe Bioengineered Protein Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Bioengineered Protein Drugs by Type (2012-2017) Figure Europe Bioengineered Protein Drugs Sales Growth Rate (%) by Type (2012-2017) Table Europe Bioengineered Protein Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Europe Bioengineered Protein Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Bioengineered Protein Drugs by Type (2012-2017) Figure Europe Bioengineered Protein Drugs Revenue Growth Rate by Type (2012-2017) Table Europe Bioengineered Protein Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table Europe Bioengineered Protein Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Bioengineered Protein Drugs by Regions (2012-2017) Figure Europe Bioengineered Protein Drugs Sales Market Share by Regions in 2017 Table Europe Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table Europe Bioengineered Protein Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Bioengineered Protein Drugs by Regions (2012-2017) Figure Europe Bioengineered Protein Drugs Revenue Market Share by Regions in 2017 Table Europe Bioengineered Protein Drugs Sales (K Units) and Market Share by Application (2012-2017) Table Europe Bioengineered Protein Drugs Sales Share (%) by Application (2012-2017) Figure Europe Bioengineered Protein Drugs Sales Market Share by Application (2012-2017) Figure Europe Bioengineered Protein Drugs Sales Market Share by Application (2012-2017) Figure Germany Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure Germany Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Germany Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Germany Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Germany Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Germany Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Germany Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Germany Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Germany Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure UK Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure UK Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure UK Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table UK Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table UK Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure UK Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table UK Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table UK Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure UK Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure France Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure France Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure France Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table France Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table France Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure France Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table France Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table France Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure France Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure Russia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Russia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Russia Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Russia Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Russia Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Russia Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Russia Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Russia Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Russia Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure Italy Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Italy Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Italy Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Italy Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Italy Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Italy Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Italy Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Italy Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Italy Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure Benelux Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Benelux Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Benelux Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Benelux Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Benelux Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Benelux Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Benelux Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Benelux Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Benelux Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure Spain Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Spain Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Spain Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Spain Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Spain Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Spain Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Spain Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Spain Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Spain Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Europe Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Bioengineered Protein Drugs Price and Trend Forecast (2018-2023) Table Europe Bioengineered Protein Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure Europe Bioengineered Protein Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Europe Bioengineered Protein Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table Europe Bioengineered Protein Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure Europe Bioengineered Protein Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure Europe Bioengineered Protein Drugs Revenue Market Share Forecast by Regions in 2023 Figure Germany Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Germany Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure France Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure France Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure UK Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure UK Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Russia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Russia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Italy Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Italy Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Spain Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Spain Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Europe Bioengineered Protein Drugs Sales (K Units) Forecast by Type (2018-2023) Figure Europe Bioengineered Protein Drugs Sales Market Share Forecast by Type (2018-2023) Table Europe Bioengineered Protein Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure Europe Bioengineered Protein Drugs Revenue Market Share Forecast by Type (2018-2023) Table Europe Bioengineered Protein Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table Europe Bioengineered Protein Drugs Sales (K Units) Forecast by Application (2018-2023) Figure Europe Bioengineered Protein Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbott Laboratories F. Hoffmann-La Roche Ltd Amgen, Inc. Bayer AG Merck & Co., Inc. Dr. Reddy's Laboratories Ltd. Biocon Ltd. Eli Lilly and Company Sanofi GlaxoSmithKline plc Johnson & Johnson JanssenNovartis AG Panacea Biotec ProBioGen AG